Pulse Biosciences, Inc.PLSENASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank55
5Y CAGR+70.3%
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

5Y CAGR
+70.3%/yr
Long-term compound
Percentile
P55
Within normal range
vs 5Y Ago
14.3x
Strong expansion
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202533.89%
202451.62%
2023-39.26%
2022-23.21%
202147.99%
20202.37%
201911.38%
201829.30%
2017428.57%
2016139.58%